New preclinical data on therapeutic 3D bioprinted human liver tissue for inborn errors of metabolism

Organovo will present this new data at The Liver Meeting® 2017 (American Association for the Study of Liver Diseases, Washington, DC, USA, 20–24 October, 2017). In new data released today, Organovo (CA, USA) has shown extended survival and sustained functionality of its 3D bioprinted human liver tissue when implanted into diseased animal models. This data will be presented at The Liver Meeting 2017 (American Association for the Study of Liver Diseases) by Vaidehi Joshi, Scientist I, Therapeutics (Organovo). Organovo has previously implanted its 3D bioprinted human liver tissue patches onto the livers of healthy NOD/SCID mice and is now presenting...